The Clinical Status of Stem Cell Therapy for Ischemic Cardiomyopathy
Ischemic cardiomyopathy (ICM) is becoming a leading cause of morbidity and mortality in the whole world. Stem cell-based therapy is emerging as a promising option for treatment of ICM. Several stem cell types including cardiac-derived stem cells (CSCs), bone marrow-derived stem cells, mesenchymal st...
Saved in:
| Main Authors: | Xianyun Wang, Jun Zhang, Fan Zhang, Jing Li, Yaqi Li, Zirui Tan, Jie Hu, Yixin Qi, Quanhai Li, Baoyong Yan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2015/135023 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in the Treatment of Ischemic Diseases by Mesenchymal Stem Cells
by: Shujing Li, et al.
Published: (2016-01-01) -
The Application Potential and Advance of Mesenchymal Stem Cell-Derived Exosomes in Myocardial Infarction
by: Xianyun Wang, et al.
Published: (2021-01-01) -
Nanoparticles-Assisted Stem Cell Therapy for Ischemic Heart Disease
by: Kai Zhu, et al.
Published: (2016-01-01) -
Clinical observational studies of potential participants’ current negative affect status for a clinical study of stem cell therapy for ischemic stroke: study protocol
by: Xixian Qin, et al.
Published: (2025-04-01) -
Application and Research of Left Bundle Branch-Optimized Cardiac Resynchronization Therapy in Ischemic Cardiomyopathy
by: Denghong Zhang, et al.
Published: (2025-03-01)